Identification and characterisation of an Iron-responsive candidate probiotic

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Bailey, Jennifer R ^a   Probert, Christopher S J ^a   Cogan, Tristan A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; IRON; PROBIOTIC AGENT; NORADRENALIN;

ANTIBACTERIAL ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CELL JUNCTION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG BIOAVAILABILITY; DRUG DETERMINATION; EFFECTOR CELL; EPITHELIUM CELL; ESCHERICHIA COLI; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; STREPTOCOCCUS THERMOPHILUS; T LYMPHOCYTE; TH1 CELL; TH17 CELL; BIOSYNTHESIS; CYTOLOGY; GROWTH, DEVELOPMENT AND AGING; INTESTINE MUCOSA; METABOLISM;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS THERMOPHILUS;

CELL PROLIFERATION; HUMANS; INTERLEUKIN-8; INTESTINAL MUCOSA; IRON; NF-KAPPA B; NOREPINEPHRINE; PROBIOTICS; STREPTOCOCCUS THERMOPHILUS; T-LYMPHOCYTES;

EID: 80054781997     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026507     Document Type: Article

References (44)

1. Metchnikoff E, Mitchell PC, (1907) The prolongation of life; optimistic studies. London, New York W. Heinemann; G.P. Putnam's Sons.
2. Report of a joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria (October 2001). "Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria". Food and Agriculture Organization of the United Nations, World Health Organization.http://www.who.int/entity/foodsafety/publications/fs_management/en/probiotics.pdf.
3. Ivory K, Chambers SJ, Pin C, Prieto E, Arques JL, et al. (2008) Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clinical & Experimental Allergy 38: 1282-1289.
4. Majamaa H, Isolauri E, (1997) Probiotics: a novel approach in the management of food allergy. Journal of Allergy & Clinical Immunology 99: 179-185.
5. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S, (2000) Probiotics in the management of atopic eczema. Clinical & Experimental Allergy 30: 1604-1610.
6. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, et al. (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076-1079.
7. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E, (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361: 1869-1871.
8. Kalliomaki M, Salminen S, Poussa T, Isolauri E, (2007) Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. Journal of Allergy & Clinical Immunology 119: 1019-1021.
9. Abrahamsson TR, Jakobsson T, Bottcher MF, Fredrikson M, Jenmalm MC, et al. (2007) Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. Journal of Allergy & Clinical Immunology 119: 1174-1180.
10. West CE, Hammarstrom ML, Hernell O, (2009) Probiotics during weaning reduce the incidence of eczema. Pediatric Allergy & Immunology 20: 430-437.
11. Szajewska H, Skorka A, Ruszczynski M, Gieruszczak-Bialek D, (2007) Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Alimentary Pharmacology & Therapeutics 25: 871-881.
12. McFarland LV, (2007) Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Medicine & Infectious Disease 5: 97-105.
13. Hickson M, D'Souza AL, Muthu N, Rogers TR, Want S, et al. (2007) Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 335: 80.
14. Haller D, Antoine JM, Bengmark S, Enck P, Rijkers GT, et al. (2010) Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. Journal of Nutrition 140: 690S-697S.
15. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT, (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354: 635-639.
16. Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E, et al. (1999) Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics 13: 1103-1108.
17. Tursi A, Brandimarte G, Giorgetti GM, Forti G, Modeo ME, et al. (2004) Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Medical Science Monitor 10: PI126-131.
18. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, et al. (2005) VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. American Journal of Gastroenterology 100: 1539-1546.
19. Pineton de Chambrun G, Colombel JF, Poulain D, Darfeuille-Michaud A, (2008) Pathogenic agents in inflammatory bowel diseases. Current Opinion in Gastroenterology 24: 440-447.
20. Pandey A, Bringel F, Meyer JM, (1994) Iron Requirement and Search for Siderophores in Lactic-Acid Bacteria. Applied Microbiology and Biotechnology 40: 735-739.
21. Bruyneel B, Vandewoestyne M, Verstraete W, (1989) Lactic-Acid Bacteria- Microorganisms Able to Grow in the Absence of Available Iron and Copper. Biotechnology Letters 11: 401-406.
22. Imbert M, Blondeau R, (1998) On the iron requirement of lactobacilli grown in chemically defined medium. Current Microbiology 37: 64-66.
23. Archibald F, (1986) Manganese: its acquisition by and function in the lactic acid bacteria. Critical Reviews in Microbiology 13: 63-109.
24. Wooldridge KG, Williams PH, (1993) Iron uptake mechanisms of pathogenic bacteria. FEMS Microbiology Reviews 12: 325-348.
25. Freestone PP, Haigh RD, Williams PH, Lyte M, (1999) Stimulation of bacterial growth by heat-stable, norepinephrine-induced autoinducers. FEMS Microbiology Letters 172: 53-60.
26. Sandrini SM, Shergill R, Woodward J, Muralikuttan R, Haigh RD, et al. (2010) Elucidation of the mechanism by which catecholamine stress hormones liberate iron from the innate immune defense proteins transferrin and lactoferrin. Journal of Bacteriology 192: 587-594.
27. Subramanian S, Rhodes JM, Hart CA, Tam B, Roberts CL, et al. (2008) Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine. Inflammatory Bowel Diseases 14: 162-175.
28. Hoffmann M, Rath E, Hölzlwimmer G, Quintanilla-Martinez L, Loach D, et al. (2008) Lactobacillus reuteri 100-23 transiently activates intestinal epithelial cells of mice that have a complex microbiota during early stages of colonization. Journal of Nutrition 138: 1684-1691.
29. van Baarlen P, Troost FJ, van Hemert S, van der Meer C, de Vos WM, et al. (2009) Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proceedings of the National Academy of Sciences of the United States of America 106: 2371-2376.
30. Singh UP, Venkataraman C, Singh R, Lillard JW Jr, (2007) CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. Endocrine, Metabolic & Immune Disorders Drug Targets 7: 111-123.
31. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences of the United States of America 105: 16731-16736.
32. Roselli M, Finamore A, Nuccitelli S, Carnevali P, Brigidi P, et al. (2009) Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflammatory Bowel Diseases 15: 1526-1536.
33. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, et al. (2010) Generation of regulatory dendritic cells and CD4+Foxp3+T cells by probiotics administration suppresses immune disorders. Proceedings of the National Academy of Sciences of the United States of America 107: 2159-2164.
34. Freestone PP, Williams PH, Haigh RD, Maggs AF, Neal CP, et al. (2002) Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock 18: 465-470.
35. Hafez M, Hayes K, Goldrick M, Grencis RK, Roberts IS, (2010) The K5 capsule of Escherichia coli strain Nissle 1917 is important in stimulating expression of Toll-like receptor 5, CD14, MyD88, and TRIF together with the induction of interleukin-8 expression via the mitogen-activated protein kinase pathway in epithelial cells. Infection & Immunity 78: 2153-2162.
36. Pagnini C, Saeed R, Bamias G, Arseneau KO, Pizarro TT, et al. (2010) Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci U S A 107: 454-459.
37. Gronbach K, Eberle U, Muller M, Olschlager TA, Dobrindt U, et al. (2010) Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host. Infection & Immunity 78: 3036-3046.
38. Anukam KC, Osazuwa EO, Osadolor HB, Bruce AW, Reid G, (2008) Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. Journal of Clinical Gastroenterology 42: 239-243.
39. Furet JP, Quenee P, Tailliez P, (2004) Molecular quantification of lactic acid bacteria in fermented milk products using real-time quantitative PCR. International Journal of Food Microbiology 97: 197-207.
40. Rodriguez C, Medici M, Mozzi F, Font de Valdez G, (2010) Therapeutic effect of Streptococcus thermophilus CRL 1190-fermented milk on chronic gastritis. World Journal of Gastroenterology 16: 1622-1630.
41. Burke JP, Mulsow JJ, O'Keane C, Docherty NG, Watson RW, et al. (2007) Fibrogenesis in Crohn's disease. Am J Gastroenterol 102: 439-448.
42. Inman CF, Rees LE, Barker E, Haverson K, Stokes CR, et al. (2005) Validation of computer-assisted, pixel-based analysis of multiple-colour immunofluorescence histology. Journal of Immunological Methods 302: 156-167.
43. Sturm A, Krivacic KA, Fiocchi C, Levine AD, (2004) Dual function of the extracellular matrix: stimulatory for cell cycle progression of naive T cells and antiapoptotic for tissue-derived memory T cells. Journal of Immunology 173: 3889-3900.
44. Stallmach A, Giese T, Pfister K, Wittig BM, Kunne S, et al. (2001) Activation of beta(1) integrins mediates proliferation and inhibits apoptosis of intestinal CD4-positive lymphocytes. European Journal of Immunology 31: 1228-1238.